Literature DB >> 22120912

Use of four MitraClip devices in a patient with ischemic cardiomyopathy and mitral regurgitation: "zipping by clipping".

Stephan Kische1, Christoph Nienaber, Hüseyin Ince.   

Abstract

Severe mitral regurgitation (MR) as a consequence of underlying left ventricular dysfunction substantially contributes to morbidity and mortality. A variety of percutaneous treatment options for mitral valve repair have been developed; however, most of these techniques are still at an early stage of clinical evaluation. Today, percutaneous edge-to-edge mitral valve repair using the MitraClip® system is the only endovascular approach that demonstrated noninferiority when compared with standard surgical repair in a randomized trial. However, a considerable number of patients with functional MR will present with extensive annulus dilatation and minimal vertical leaflet coaptation that potentially preclude them from this beneficial technology for anatomical reasons. In this report, we portray a 72-year-old man presenting with end-stage systolic heart failure and severe functional MR as a consequence of long-standing coronary artery disease. Recently, his clinical course was complicated by intractable hemodynamic instability and recurrent pulmonary edema. High predicted mortality and progressive physical decay rendered this moribund patient a candidate for salvage percutaneous mitral valve repair. During the endovascular procedure, a central systolic coaptation gap of 7 mm proved to be too wide for adequate simultaneous grasping of both leaflets. Consideration was given to an alternative approach by means of our novel "zipping technique." Through the trans-septal route, medial to lateral approximation of the tethered leaflets was successfully achieved by intentional deployment of four MitraClip® devices. With the first in-human application of four mechanical implants, a profound reduction of MR grade has been accomplished by the creation of a lateral neo-orifice with apparent acute clinical success. However, it needs to be determined whether successful application of the zipping technique leads to sustained reverse ventricular remodeling and will translate into an improved long-term prognosis.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22120912     DOI: 10.1002/ccd.23431

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  6 in total

1.  Mitral valve with three orifices after percutaneous repair with the MitraClip system: the triple-orifice technique.

Authors:  L Paranskaya; S Kische; I Bozdag-Turan; C Nienaber; H Ince
Journal:  Clin Res Cardiol       Date:  2012-03-31       Impact factor: 5.460

2.  Initial clinical experience using the EchoNavigator(®)-system during structural heart disease interventions.

Authors:  Jan Balzer; Tobias Zeus; Katharina Hellhammer; Verena Veulemans; Silke Eschenhagen; Eva Kehmeier; Christian Meyer; Tienush Rassaf; Malte Kelm
Journal:  World J Cardiol       Date:  2015-09-26

3.  Implantation of a MitraClip between two previously implanted MitraClips to treat recurrent severe mitral regurgitation.

Authors:  Hasema Lesevic; Carolin Sonne; Albert Markus Kasel; Dietmar Breuer; Adnan Kastrati; Heribert Schunkert; Ilka Ott
Journal:  J Cardiol Cases       Date:  2016-11-17

4.  Initial Slovenian experience with MitraClip therapy : Careful selection of patients is crucial for optimal outcome.

Authors:  Jana Ambrožič; Marta Cvijič; Mojca Bervar; Špela Mušič; Matjaž Bunc
Journal:  Wien Klin Wochenschr       Date:  2017-12-04       Impact factor: 1.704

5.  Hybrid Imaging in the Catheter Laboratory: Real-time Fusion of Echocardiography and Fluoroscopy During Percutaneous Structural Heart Disease Interventions.

Authors:  Jan Balzer; Tobias Zeus; Verena Veulemans; Malte Kelm
Journal:  Interv Cardiol       Date:  2016-05

Review 6.  Mitral Valve Surgery: Current Minimally Invasive and Transcatheter Options.

Authors:  Basel Ramlawi; James S Gammie
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.